Atherosclerotic Cardiovascular Disease and Cancer
Immunological Reviews · 2026-07 · 340 (1)
DOI: 10.1111/imr.70141 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 12.07.2026. Verfasst von Anaïs Amend und 4 weiteren Autor:innen. Beteiligte Einrichtung: Leon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Neoplasms, Atherosclerosis, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, American Heart Association.
Abstract (Originalsprache)
Atherosclerotic cardiovascular disease (ASCVD) and cancer are increasingly recognized as interconnected diseases linked by shared immune mechanisms rather than merely overlapping risk factors. Common exposures such as smoking, obesity, diabetes, and dyslipidemia, together with aging and clonal hematopoiesis of indeterminate potential (CHIP), establish a chronic inflammatory milieu that drives both pathologies through coordinated reprogramming of myeloid and lymphoid compartments. Within this framework, a forward cardio‐oncology axis is increasingly recognized, in which cancer therapies including chemotherapies, radiation, and immune checkpoint inhibitors induce cardiovascular injury, manifesting as cardiomyopathy, accelerated atherosclerosis, and immune‐mediated myocarditis. Complementing this, a reverse axis has emerged in which cardiovascular injury states such as myocardial infarction, ischemia, and heart failure actively promote cancer initiation and progression through hematopoietic remodeling, extracellular vesicle‐mediated communication, cardiac‐derived factors, and immunosuppressive myeloid bias. At the tissue level, immune checkpoint pathways including PD‐1, PD‐L1, CTLA‐4, LAG‐3, and TIM‐3 form spatially organized regulatory networks within atherosclerotic plaques. Their therapeutic perturbation restores T cell activity but may disrupt local immune homeostasis and promote plaque instability. In parallel, inflammatory cytokines such as IL‐1β, IL‐6, and TNF‐α, often amplified by CHIP‐associated clones, provide a mechanistic bridge linking atherogenesis with tumor immune evasion. Together, these observations support a unified view of ASCVD and cancer as immune‐driven diseases connected by bidirectional axes of interaction. This review integrates emerging mechanistic and clinical evidence and outlines how immune‐based stratification and targeted modulation of inflammation may enable more precise management of patients at the intersection of cardiovascular disease and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
- Cardiovascular Research Center, NYU Langone Health, New York, New York, USA.
- Division of Cardiology, Center for Cardiovascular Research, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
- Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
- Department of Pathology, NYU Grossman School of Medicine, New York, New York, USA.
- Department of Cell Biology, NYU Grossman School of Medicine, New York, New York, USA.
ORCID-Profile: Anaïs Amend, Kathryn J Moore
Förderung
- NIH HHS
- NHLBI NIH HHS
- American Heart Association
- Fondation Leducq
- DFG
- National Institutes of Health
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Amend, A., Horstmann, H., Lavine, K. J., Giannarelli, C., & Moore, K. J. (2026). Atherosclerotic Cardiovascular Disease and Cancer. Immunological Reviews, 340(1). https://doi.org/10.1111/imr.70141
Vancouver
Amend A, Horstmann H, Lavine KJ, Giannarelli C, Moore KJ. Atherosclerotic Cardiovascular Disease and Cancer. Immunological Reviews. 2026;340(1). doi:10.1111/imr.70141
BibTeX
@article{Amend2026,
author = {Amend, Anaïs and Horstmann, Hauke and Lavine, Kory J and Giannarelli, Chiara and Moore, Kathryn J},
title = {Atherosclerotic Cardiovascular Disease and Cancer},
journal = {Immunological Reviews},
year = {2026},
volume = {340},
number = {1},
doi = {10.1111/imr.70141}
}
EUVIMED